Page last updated: 2024-08-17

levodopa and Essential Tremor

levodopa has been researched along with Essential Tremor in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's8 (42.11)29.6817
2010's7 (36.84)24.3611
2020's3 (15.79)2.80

Authors

AuthorsStudies
Constantinescu, M; Nassar, M; Schlesinger, I; Sinai, A; Sprecher, E; Zaaroor, M1
Amami, P; Bocchi, E; Bonvegna, S; Bruzzone, MG; Ciceri, EFM; Cilia, R; Devigili, G; Eleopra, R; Elia, AE; Gasparini, V; Ghielmetti, F; Golfrè Andreasi, N; Grisoli, M; Levi, V; Messina, G; Novelli, A; Piacentini, SHMJ; Prioni, S; Rinaldo, S; Romito, LM; Stanziano, M; Straccia, G; Tringali, G1
Baumann, CR; Oertel, MF; Stieglitz, LH1
Warnke, P1
Rajput, A; Rajput, AH; Rajput, ML; Robinson, CA1
Ahlskog, JE; Josephs, KA; Klassen, BT; Lee, KH; Matsumoto, JY; Savica, R; Stead, M1
Akdeniz, M; Yaman, A; Yaman, H1
Burkhard, PR; Vingerhoets, FJ1
Ankaralı, H; Gunal, DI; Mollahasanoğlu, A; Ozen Barut, B; Turkmen, C1
Shweikeh, F; Zahos, PA1
Ghika, J; Solida, A; Vingerhoets, F1
Sethi, KD1
Rajput, A; Rajput, AH; Robinson, CA1
Ahlskog, JE; Josephs, KA; Matsumoto, JY1
Linazasoro, G; Magariños, C; Van Blercom, N1
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y1
Brown, P; Eusebio, A1
Lee, SS; Lum, SY; S, FC; Tan, EK1
Weiner, WJ1

Reviews

5 review(s) available for levodopa and Essential Tremor

ArticleYear
How best to address these common movement disorders.
    The Journal of family practice, 2011, Volume: 60, Issue:12

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2011
[Resistance to treatment in movement disorders].
    Revue medicale suisse, 2012, May-02, Volume: 8, Issue:339

    Topics: Antiparkinson Agents; Apomorphine; Deep Brain Stimulation; Drug Resistance; Essential Tremor; Humans; Levodopa; Movement Disorders; Neurosurgery; Parkinson Disease; Treatment Failure

2012
Tremor.
    Current opinion in neurology, 2003, Volume: 16, Issue:4

    Topics: Acetates; Amines; Anticonvulsants; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Electromyography; Essential Tremor; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Levodopa; Motor Cortex; Muscle, Skeletal; Parkinson Disease; Posture; Primidone; Randomized Controlled Trials as Topic; Severity of Illness Index; Somatosensory Cortex; Topiramate; Tremor

2003
Paradoxes of functional neurosurgery: clues from basal ganglia recordings.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23, Issue:1

    Topics: Antiparkinson Agents; Basal Ganglia; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Dystonia; Essential Tremor; Globus Pallidus; Humans; Levodopa; Movement Disorders; Neurosurgical Procedures; Parkinson Disease

2008
The initial treatment of Parkinson's disease should begin with levodopa.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors

1999

Trials

1 trial(s) available for levodopa and Essential Tremor

ArticleYear
Benign tremulous parkinsonism.
    Archives of neurology, 2006, Volume: 63, Issue:3

    Topics: Adult; Aged; Antiparkinson Agents; Essential Tremor; Family Health; Female; Humans; Levodopa; Longitudinal Studies; Male; Medical Records Systems, Computerized; Middle Aged; Parkinsonian Disorders; Treatment Outcome

2006

Other Studies

13 other study(ies) available for levodopa and Essential Tremor

ArticleYear
Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson's Disease: Long-Term Results.
    Journal of Parkinson's disease, 2022, Volume: 12, Issue:1

    Topics: Aged; Essential Tremor; Humans; Levodopa; Middle Aged; Parkinson Disease; Thalamus; Treatment Outcome; Tremor

2022
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study.
    Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:11

    Topics: Essential Tremor; Humans; Levodopa; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects; Thalamus; Treatment Outcome; Tremor

2022
[Movement Disorders: What Are You Doing? What Can We Do?]
    Praxis, 2020, Volume: 109, Issue:6

    Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Dopamine Agonists; Essential Tremor; Humans; Levodopa; Parkinson Disease

2020
Deep brain stimulation for movement disorders: what counts in the end is the end result.
    Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:5

    Topics: Antiparkinson Agents; Deep Brain Stimulation; Essential Tremor; Female; Humans; Levodopa; Male; Parkinson Disease; Subthalamic Nucleus

2014
Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Autopsy; Diagnostic Errors; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Young Adult

2015
Deep brain stimulation in benign tremulous parkinsonism.
    Archives of neurology, 2011, Volume: 68, Issue:8

    Topics: Adult; Aged; Cohort Studies; Deep Brain Stimulation; Disease Progression; Drug Resistance; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Patient Selection; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome; Tremor; Ventral Thalamic Nuclei

2011
Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor.
    Acta neurologica Belgica, 2013, Volume: 113, Issue:2

    Topics: Aged; Aged, 80 and over; Anticonvulsants; Antiparkinson Agents; Attention; Cognition; Cognition Disorders; Essential Tremor; Executive Function; Female; Humans; Levodopa; Male; Memory; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Primidone; Space Perception

2013
Frameless deep brain stimulation surgery: a community hospital experience.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Data Interpretation, Statistical; Deep Brain Stimulation; Essential Tremor; Female; Follow-Up Studies; Hospitals, Community; Humans; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Treatment Outcome

2013
Acute dopaminergic challenge tests to assess postural/kinetic tremor of different origin: a case report.
    Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 73, Issue:2

    Topics: Aged; Antiparkinson Agents; Apomorphine; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Electromyography; Essential Tremor; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Posture; Receptors, Dopamine

2002
Essential tremor course and disability: A clinicopathologic study of 20 cases.
    Neurology, 2004, Mar-23, Volume: 62, Issue:6

    Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive

2004
Three in one: case report supporting different origins of essential and parkinsonian tremors.
    European neurology, 2006, Volume: 55, Issue:2

    Topics: Aged; Antiparkinson Agents; Antithyroid Agents; Combined Modality Therapy; Deep Brain Stimulation; Diagnosis, Differential; Essential Tremor; Female; Humans; Hyperthyroidism; Levodopa; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Tremor; Ventral Thalamic Nuclei

2006
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13

    Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats

2007
Evidence of increased odds of essential tremor in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Essential Tremor; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index

2008